Rheumatology
Partner With Us
Advertisement
Conexiant chevron_right Rheumatology chevron_right GLP1 Use Reduces Opioid Pain Fatigue Burdenin Fibromyalgia
Conference News EULAR 2025 - Congress

GLP-1 Use Associated with Less Pain, Fatigue

At the EULAR 2025 Congress, researchers reported that GLP-1 receptor agonists were linked to reduced opioid use, pain, and fatigue in fibromyalgia patients based on a large real-world analysis.

Conexiant
Full Article Summary Notecard
Real-world evidence presented at the 2025 EULAR Congress suggests that GLP-1 receptor agonists may reduce symptom burden in patients with fibromyalgia, indicating lower opioid use, pain, fatigue, and ongoing fibromyalgia care. The analysis used data from the TriNetX research network, comparing large patient cohorts over a 5-year follow-up period. However, the observational design limits causal conclusions, warranting further evaluation through randomized controlled trials.

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.